TILT Holdings (TLLTF) Other financing activities (2021 - 2023)

TILT Holdings (TLLTF) reported Other financing activities of $294000.0 for Q3 2023, up 59.78% quarter-over-quarter from $184000.0 in Q2 2023.

TILT Holdings (TLLTF) Other financing activities (2021 - 2023) Analysis & Trends

TILT Holdings has reported Other financing activities for 2 years, with the latest figure at $294000.0 in Q3 2023.

For the quarter ending Q3 2023, Other financing activities changed N/A year-over-year to $294000.0; the trailing twelve-month figure through Dec 2023 stood at $1.5 million (changed N/A YoY), and the FY2024 full-year result was $560000.0, down 62.84% from the prior year.
Other financing activities for Q3 2023 stood at $294000.0, up from $184000.0 in the prior quarter.
The five-year high for Other financing activities was $1.0 million in Q1 2023, with the low at $51000.0 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	TILT Holdings	-	-	1.82 Mn

Download Data